Tuberculosis of prostate
ICD-10 A18.14 is a billable code used to indicate a diagnosis of tuberculosis of prostate.
Tuberculosis of the prostate is a rare form of extrapulmonary tuberculosis that occurs when Mycobacterium tuberculosis infects the prostate gland. This condition is often secondary to pulmonary tuberculosis, where the bacteria disseminate through the bloodstream or lymphatic system. Patients may present with symptoms such as dysuria, pelvic pain, and urinary retention. Diagnosis typically involves a combination of clinical evaluation, imaging studies, and microbiological tests. Transrectal ultrasound-guided biopsy may be necessary to confirm the presence of granulomatous inflammation or acid-fast bacilli in prostatic tissue. Treatment usually consists of a multi-drug regimen similar to that used for pulmonary tuberculosis, including isoniazid, rifampicin, pyrazinamide, and ethambutol, administered for at least six months. Monitoring for drug resistance is crucial, as treatment failure can occur due to non-compliance or the presence of resistant strains. Public health implications include the need for contact tracing and isolation of infectious cases to prevent transmission. Given the rarity of this condition, awareness and proper coding are essential for accurate epidemiological tracking and resource allocation.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with urinary symptoms and a history of tuberculosis.
Awareness of the need for biopsy and the interpretation of results in the context of tuberculosis.
Comprehensive history of tuberculosis exposure, treatment history, and drug resistance testing.
Patients with systemic symptoms and a known history of tuberculosis.
Coordination with urology for management of complications related to the prostate.
Used when a biopsy is performed to confirm tuberculosis.
Document the indication for biopsy and results.
Urologists should ensure proper technique and follow-up.
Common symptoms include dysuria, pelvic pain, urinary retention, and systemic symptoms such as fever and weight loss.
Diagnosis typically involves clinical evaluation, imaging studies, and biopsy to confirm the presence of Mycobacterium tuberculosis.
Treatment usually consists of a multi-drug regimen similar to that for pulmonary tuberculosis, including isoniazid, rifampicin, pyrazinamide, and ethambutol.
